BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29797599)

  • 1. Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
    Ranjbar R; Hesari A; Ghasemi F; Sahebkar A
    J Cell Biochem; 2018 Sep; 119(9):7570-7576. PubMed ID: 29797599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of microRNA-204 by Helicobacter pylori augments the NF-κB signaling pathway in gastric cancer development and progression.
    Chen P; Guo H; Wu X; Li J; Duan X; Ba Q; Wang H
    Carcinogenesis; 2020 Jun; 41(4):430-441. PubMed ID: 31873718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA‑146a inhibits the inflammatory responses induced by interleukin‑17A during the infection of Helicobacter pylori.
    Li N; Wang J; Yu W; Dong K; You F; Si B; Tang B; Zhang Y; Wang T; Qiao B
    Mol Med Rep; 2019 Feb; 19(2):1388-1395. PubMed ID: 30535468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobactor pylori cagA (+) infection.
    Yang GF; Deng CS; Xiong YY; Gong LL; Wang BC; Luo J
    World J Gastroenterol; 2004 Feb; 10(4):491-6. PubMed ID: 14966904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis.
    Hayashi Y; Tsujii M; Wang J; Kondo J; Akasaka T; Jin Y; Li W; Nakamura T; Nishida T; Iijima H; Tsuji S; Kawano S; Hayashi N; Takehara T
    Gut; 2013 Nov; 62(11):1536-46. PubMed ID: 22936674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori infection modulates the expression of miRNAs associated with DNA mismatch repair pathway.
    Santos JC; Brianti MT; Almeida VR; Ortega MM; Fischer W; Haas R; Matheu A; Ribeiro ML
    Mol Carcinog; 2017 Apr; 56(4):1372-1379. PubMed ID: 27862371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different microRNA expression levels in gastric cancer depending on Helicobacter pylori infection.
    Chang H; Kim N; Park JH; Nam RH; Choi YJ; Lee HS; Yoon H; Shin CM; Park YS; Kim JM; Lee DH
    Gut Liver; 2015 Mar; 9(2):188-96. PubMed ID: 25167801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
    Gao C; Zhang Z; Liu W; Xiao S; Gu W; Lu H
    Cancer; 2010 Jan; 116(1):41-9. PubMed ID: 19890957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c.
    Zhou X; Chen H; Zhu L; Hao B; Zhang W; Hua J; Gu H; Jin W; Zhang G
    Oncotarget; 2016 Dec; 7(50):82770-82782. PubMed ID: 27835575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Changes in Gastric Carcinogenesis: Differential Dysregulation during
    Prinz C; Mese K; Weber D
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mir-30d increases intracellular survival of Helicobacter pylori through inhibition of autophagy pathway.
    Yang XJ; Si RH; Liang YH; Ma BQ; Jiang ZB; Wang B; Gao P
    World J Gastroenterol; 2016 Apr; 22(15):3978-91. PubMed ID: 27099441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB/miR-18a-3p and miR-4286/BZRAP1 axis may mediate carcinogenesis in Helicobacter pylori-Associated gastric cancer.
    Tsai CC; Chen TY; Tsai KJ; Lin MW; Hsu CY; Wu DC; Tsai EM; Hsieh TH
    Biomed Pharmacother; 2020 Dec; 132():110869. PubMed ID: 33113427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2.
    Zhou X; Xia Y; Li L; Zhang G
    Cancer Biol Ther; 2015; 16(1):160-9. PubMed ID: 25561270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-24-3p Regulates Progression of Gastric Mucosal Lesions and Suppresses Proliferation and Invasiveness of N87 Via Peroxiredoxin 6.
    Li Q; Wang N; Wei H; Li C; Wu J; Yang G
    Dig Dis Sci; 2016 Dec; 61(12):3486-3497. PubMed ID: 27743162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer.
    Shao L; Chen Z; Soutto M; Zhu S; Lu H; Romero-Gallo J; Peek R; Zhang S; El-Rifai W
    FASEB J; 2019 Jan; 33(1):264-274. PubMed ID: 29985646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells.
    Liu Z; Xiao B; Tang B; Li B; Li N; Zhu E; Guo G; Gu J; Zhuang Y; Liu X; Ding H; Zhao X; Guo H; Mao X; Zou Q
    Microbes Infect; 2010 Oct; 12(11):854-63. PubMed ID: 20542134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2.
    Wang F; Liu J; Zou Y; Jiao Y; Huang Y; Fan L; Li X; Yu H; He C; Wei W; Wang H; Sun G
    Oncotarget; 2017 Apr; 8(17):28711-28724. PubMed ID: 28404925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer.
    Tsai MM; Huang HW; Wang CS; Lee KF; Tsai CY; Lu PH; Chi HC; Lin YH; Kuo LM; Lin KH
    Oncotarget; 2016 Jun; 7(26):39511-39526. PubMed ID: 27078844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of miR-222 in both Helicobacter pylori- infected and noninfected gastric cancer patients.
    Noormohammad M; Sadeghi S; Tabatabaeian H; Ghaedi K; Talebi A; Azadeh M; Khatami M; Heidari MM
    J Genet; 2016 Dec; 95(4):991-995. PubMed ID: 27994199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis.
    Fassan M; Saraggi D; Balsamo L; Cascione L; Castoro C; Coati I; De Bernard M; Farinati F; Guzzardo V; Valeri N; Zambon CF; Rugge M
    Oncotarget; 2016 Jan; 7(4):4915-24. PubMed ID: 26701848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.